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1. Introduction 
During the past decades, an increase in several pediatric morbid conditions has been well 
documented. Two of the most important of these conditions are obesity and asthma. While 
the increase of asthma prevalence has been explained in part by the so-called hygiene 
hypothesis, which claims for a shift from a Th1 to a Th2 environment (if the immunological 
system does not have to deal with infections –Th1- due to a much more aseptic 
environment, it will turn to an allergic predisposition –Th2) (von Mutius, 2007). However, 
this hypothesis does not explain the high prevalences among inner city populations (Platts-
Mills et al., 2005) or developing countries as found in the International Study of Asthma and 
Allergies in Childhood (ISAAC) (Asher et al., 2006). On the other hand, the increased 
prevalence of obesity is most probably due to an imbalance between the energy intake (both 
in quantity as well as quality) and the expenditure, in which the lack of exercise is a key 
point. In this chapter we will explore the complex relationship between asthma, obesity diet 
and exercise in children. 
2. Obesity and asthma are linked together 
2.1 The epidemiological link 
In this section some of the epidemiological evidence regarding the link between asthma and 
obesity is reviewed.  
2.1.1 Obesity/overweight is associated and precedes asthma 
Numerous studies support the epidemiological association between asthma and obesity. 
Though many of them are cross-sectional, thus making it difficult to establish a casual 
relationship, some have been specifically aimed at disentangling the first question of which 
is first in those two apparently connected diseases. The meta-analysis by Sutherland and 
Beuther  (Beuther & Sutherland, 2007) included seven studies which fulfilled their criteria of 
including adult individuals followed for at least one year in which the main outcome 
variable was incident asthma and whose obesity was measured using body mass index 
(BMI). The aforementioned studies included more than 300,000 individuals and the result 
clearly demonstrated that BMI was associated to incident asthma in a dose-response 
manner: the association was higher with obesity than it was with overweight. 
There are also a number of epidemiological clues which suggest that obesity in childhood 
precedes asthma later in life. For instance, in a Tasmanian cohort study (Burgess et al., 2007) 
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of children recruited at the age of seven years, adiposity (defined as overweight at 7 years, 
or as highest quartile BMI) was associated with incident asthma between the ages of 21 and 
32 years in girls, but not in boys. Although the number of subjects was low, the association 
was considerably high. Similarly, females who became overweight or obese between 6 and 
11 years of age were seven times more likely to develop new asthma symptoms at ages 11 or 
13, according to the Tucson Children Respiratory Study (Castro-Rodriguez et al., 2001). 
However, not all studies have found a higher association in girls. In fact, in the Children's 
Health Study (Southern California) the risk of new-onset asthma was higher in boys than in 
girls, although it was significant in both genders. 
Not only do overweight or obesity seem to precede asthma but birth weight has also been 
shown to be related to later asthma. Although not all the reports coincide it does seem quite 
consistent that extreme high birth weights are strongly associated to asthma symptoms in 
school years (To et al., 2010). Furthermore, children with a predisposition for asthma may 
have a higher risk of developing asthma during childhood when their mothers are 
overweight before pregnancy, irrespective of the child's BMI (Scholtens et al., 2010). It is also 
of interest that infants breast fed for at least six moths have a better lung function, and this 
seems to be related to a lower weight gain. This was shown by Turner at al. (Turner et al., 
2008) who followed 154 infants from birth. Maximal flow at functional residual capacity 
(V'maxFRC) was measured at 1 and 12 months of life: the change in V'maxFRC was 
inversely associated with change in weight. The group with lower V'maxFRC at 1 month 
and reduced change in V'maxFRC over infancy had the greatest weight gain and increased 
risk for asthma symptoms by the age of three years but not afterwards. Those authors 
concluded that postnatal weight gain may be indirectly associated with early transient 
asthma symptoms which might be the result of impaired lung growth during infancy, a 
situation which could be modifiable by breast feeding. A Danish cohort study in which lung 
function was measured at 6 weeks of age showed that infants in the upper quartile of BMI 
had lower FEV0.5 (Bisgaard et al., 2009).  To what extent this circumstance of the early years 
can be translated to older ages and established asthma is difficult to say, although a 
connection between obesity and architectural changes in the lung is suggestive, especially if 
the action of adipokines (which will be reviewed later in this chapter) is taken into account.  
Taken together, epidemiological data indicate that body weight and asthma are related in 
some way, and that excess weight seems to precede asthma or asthma-related symptoms. 
This fact does not necessarily rule out that the two conditions develop in parallel with the 
former being apparent before. Furthermore, there are factors which modify the relationship 
between obesity and asthma. This has been shown in a cross-sectional study (Garcia-Marcos 
et al., 2008) including a very high number of children: although the association was highly 
significant for the whole group, it changed dramatically when the group was stratified 
between those asthmatics also suffering or not from rhinoconjunctivitis. Obesity was not a 
risk factor for those children with significant asthma who also suffered rhinoconjunctivitis. 
Although the study has limitations and rhinoconjunctivitis is not a perfect marker of atopy, 
it raises the question as to whether obesity may be related only to specific asthma 
phenotypes. 
2.1.2 Obesity and asthma develop in parallel, especially in periods of fast growth and 
maturation  
Rather than obesity being the cause of asthma, some findings support the hypothesis of 
parallel processes which may be related to a change of the environment in which children 
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develop. It is probably when development is more intense (immediately after birth and 
during puberty) when those processes may be more obvious. Some facts support this view: 
- Perinatal events (Jaakkola et al., 2006; Sukalich et al., 2006) or mother food consumption 
during pregnancy have an influence on later obesity and asthma (Chatzi et al., 2008; 
Castro-Rodriguez et al., 2010). 
- Breast feeding and dietary habits during infancy and later on, are related to obesity and 
asthma (Matheson et al., 2007); (Moreno & Rodriguez, 2007). 
- It is among pre-puberal girls where the association between obesity and asthma is most 
apparent (Castro-Rodriguez et al., 2001); (Garcia-Marcos et al., 2007), and obesity 
favours early menarche. 
- Epidemiological studies show that females who became overweight or obese between 6 
and 11 years of age were seven times more likely to develop new asthma symptoms at 
age 11 or 13 (Castro-Rodriguez et al., 2001). Moreover, the early onset of puberty has 
been associated with the persistence of asthma after puberty (Guerra et al., 2004). 
- Obesity and asthma are linked conditions during puberty. Although both obesity and 
asthma can start early in the child life, it is probably around puberty when the 
connections between those conditions may be better revealed, as some epidemiological 
studies have shown (Castro-Rodriguez et al., 2001); (Herrera-Trujillo et al., 2005). Some 
mechanisms might explain this process. For instance, leptin is a key permissive factor 
(Navarro et al., 2007) –probably through the activation of kisspeptin neurons (Kauffman 
et al., 2007)- for the onset of puberty. Furthermore, the increase in body weight which 
occurs during the pubertal spurt induces a corresponding increase of circulating leptin, 
but also of interleukin (IL)-6 and tumour necrosis factor alpha (TNF-┙). 
- Several areas in the genome are common to mediators related both to asthma and 
obesity. 
2.1.3 The association between obesity/overweight and bronchial 
hyperresponsiveness is conflicting 
A recent review by Shore (Shore, 2010) lists eight studies dealing with the association of 
obesity and bronchial hyperresponsiveness (BHR) in adults and a further eight in children. 
Except for one, all the studies in adults were carried out using metacholine in the challenge 
test. In children, there were studies using metacholine (n=3), histamine (n=1) and exercise 
(n=3). The results do not point in the same direction even in the two longitudinal studies 
(one in adults and one in children). The study in adults reported that high initial BMI was 
un-linearly associated to later BHR; and weight gain was also associated linearly with the 
risk of later BHR. On the contrary, the study performed in children (Hancox et al., 2005) did 
not find any association. Interestingly, however, a high BMI was associated to asthma only 
in women. This might indicate that the link between obesity and asthma might not 
necessarily be mediated through airway inflammation revealed by metacholine challenge 
testing. The cross-sectional studies in children which used metacholine in the challenge test 
showed all types of results: no association; association only in males; or association only in 
females. On the contrary, all three cross-sectional studies using exercise as the challenge test 
found a positive association. The cross-sectional studies in adults (none of them using 
exercise) also found mixed results, including one study which observed that BMI increased 
BHR in non-asthmatics but not in asthmatics. 
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Although a number of factors such as gender, type of challenge test, non-linear association 
between BMI and BHR (which might counteract the effect of BMI if both low and high BMI 
are associated to BHR), age groups, asthma control, lack of control for diet, etc. may explain 
the discrepancy between studies, it seems quite clear that the evidence of an association (if 
any) between BMI and BHR is not as strong as it is for asthma diagnosis or asthma 
symptoms. It is interesting that the results are concordant only for the exercise challenge test 
which does not produce smooth muscle reactivity (as metacholine does) but provokes mast 
cell activation. It might be hypothesized that obese individuals either create a different 
osmolality of the airways (the mechanism thought to be responsible for BHR with exercise) 
while exercising, which in turn causes a higher mast cell activation; or have more mast cells 
in their airways; or they are more sensitive to osmolality. Although findings in animal 
models are difficult to translate to humans, it is of great interest that obese mice sensitized 
and challenged with ovoalbumin have increased numbers of mast cells in their lungs as 
compared to lean controls (Mito et al., 2002). 
2.2 The clinical link 
Further evidence that obesity and asthma are related to each other is the fact that BMI 
predicts asthma control as an independent factor. For instance, in a very recent study, Farah 
et al. (Farah et al., 2011) reported on asthma control in 49 asthmatic subjects before and after 
three months of treatment with high doses of inhaled corticosteroids. The effects of 
treatment were stratified according to BMI (normal, overweight and obese) and the degree 
of control was assessed by means of the asthma control questionnaire (ACQ-5) although 
other variables, such as forced expiratory volume during the first second (FEV1), airways 
resistance (Rrs) and reactance (Xrs) as measured by the forced oscillation technique, BHR to 
metacholine, and exhaled nitric oxide (FeNO), were also measured before and after 
treatment. After the treatment period neither FeNO (as a surrogate of bronchial eosinophilic 
inflammation) nor FEV1 predicted asthma control according to ACQ-5. The two 
independent predictors of ACQ-5 were Rrs and BMI. The authors conclude that BMI is a 
factor which determines asthma control and is independent of airway inflammation, lung 
function and BHR. Furthermore, after ICS treatment, BMI again predicts ACQ-5, and this 
seems independent of obesity-related changes in lung mechanics. 
From a different angle, but adding some evidence to the argument, one study (Maniscalco et 
al., 2008) has shown that weight loss helps to control asthma in asthmatic individuals. In a 
series of 12 consecutive asthmatic females who had laparoscopic adjustable gastric banding 
and consecutively a significant weight loss, asthma control was significantly improved as 
compared to a control group. Interestingly, no changes in FeNO were found before and after 
the surgical procedure. Previously, another study showed that a small group of asthmatics 
(mainly women) significantly improved their asthma control after a very-low-calorie-diet 
period of 8 weeks (Hakala et al., 2000). In this case, spirometric variables significantly 
improved leading the authors to think that improvement may be due to better lung 
mechanics. To the best of our knowledge there are no controlled studies evaluating the 
effect of weight loss in obese children. 
2.3 A genetic link? 
There are some regions of the genome that are linked with both asthma and obesity, as 
occurs with chromosome 5q, 6, 11q13 and 12q (Tantisira & Weiss, 2001). Chromosome 5q 
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contains genes coding the ┚2-adrenergic receptor, which has been related to different asthma 
phenotypes, asthma severity and differential response to ┚2-agonists (Hall et al., 1995). A 
change of Gln for Glu in this receptor has been also associated to obesity (Ishiyama-
Shigemoto et al., 1999). Additionally, chromosome 5q contains the glucocorticoid receptor 
gene which has been involved in inflammatory responses associated to obesity and asthma. 
Chromosome 6 contains the gene for TNF-┙, an interleukin which is important for both 
obesity and asthma. Another genome region which is linked with asthma and with obesity 
independently is that of chromosome 11q13 which contains genes for the uncoupling 
proteins UCP2-UCP3 (related to baseline metabolism) and for the low affinity receptor for 
IgE. To end, chromosome 12 contains the genes for inflammatory cytokines both related to 
asthma (such as IFN-┛, or nitric oxide synthase-1) and to obesity (such as signal transducer 
and activator of transcription protein 6 -STAT6-, or type 1 insulinoid growth factor) 
(Delgado et al., 2008). To what extent specific but very large areas of the genome are 
involved in the genesis of the parallel development of asthma and obesity is questionable. 
How epigenetic changes taking place under certain environments might influence genome 
areas related to both diseases is even more questionable. 
2.4 The inflammation link 
The hypothesis that the increase in the prevalence of asthma and obesity, being parallel, 
could be related to one another (Chinn & Rona, 2001) seems quite plausible. However, a 
definite link between the two conditions has yet to be definitely established, as it seems to be 
related to the age and gender of the studied population (Castro-Rodriguez et al., 2001; Chen 
et al., 2002; Garcia-Marcos et al., 2007), and also to the asthma phenotype (Garcia-Marcos et 
al., 2008; Gilliland et al., 2003). However, some of the epidemiological and experimental 
information reviewed in former sections seems to indicate that obesity may precede asthma. 
To explain this, several inflammatory mechanisms have been evoked: 
2.4.1 Adipokines 
Adipokines are cytokines produced by the adipose tissue. Some of them are associated both 
to obesity and to asthma. 
2.4.1.1 Leptin 
Leptin is mainly produced by white adipose tissue proportionally to the amount of such 
tissue. Leptin production is regulated by food intake: food consumption up regulates the 
ob gene, thus increasing leptin synthesis; conversely, fasting reduces leptin levels. 
Infection and sepsis and various pro-inflammatory cytokines including TNF-┙ and IL-1 
increase leptin. Conversely to this acute response, chronic inflammation causes a 
reduction in leptin levels. Leptin is also moderated by sex hormones: while testosterone 
inhibits leptin production, ovarian sex steroids increase it, a fact which keeps up with 
gender-related dimorphism of this adipokine: leptin levels are higher in females than BMI 
and age-matched males. The main target organ for leptin is the hypothalamus in which it 
triggers efector pathways to suppress appetite and increase energy expenditure. Apart 
from the metabolic processes, leptin is also involved in other functions, including the 
immune response both innate and adaptative: it increases several pro-inflammatory 
cytokines, such as TNF-┙, IL-6 and IL-12, and increases chemotaxis and the functioning of 
natural killer cells. Overall, leptin increases Th1 and suppresses Th2 response by acting on 
T regulatory cells (Treg). The leptin receptor gene (db gene) is expressed in the lung tissue 
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of several animals and also in humans (Tsuchiya et al., 1999). Although the role of those 
receptors is not yet clear their presence indicates that the lung is a target organ for leptin. 
There is also some evidence that leptin can stimulate surfactant protein synthesis (Malli et 
al., 2010). However, the evidence that leptin influences lung growth and maturation 
comes from animal models, thus extrapolation to humans remains a major limitation. 
There also appears to be some role of leptin in respiratory function control, at least in mice 
(Groeben et al., 2004; Tankersley et al., 1996).  
Asthmatic 12-year-old children who are overweight have higher levels of leptin than 
overweight children who are not asthmatics, despite there being no difference of BMI 
between the two groups (Mai et al., 2004). This has been also shown in preschool children 
with normal weight, although reduced to male gender (Guler et al., 2004). Very 
interestingly, however, is that leptin and BMI are both associated to asthma in adults in an 
independent way, so when adjusting for leptin levels there is still an association of BMI with 
asthma (Sood et al., 2006). Furthermore, in asthmatic children leptin and IgE serum levels 
are highly correlated to each other (Guler et al., 2004). Atopic asthmatic boys have higher 
leptin levels than non-atopic asthmatic boys. The extent to which leptin has the ability to 
recruit eosinophils into the lungs and to augment leukotriene synthesis by macrophages 
may actually be the explanation of its association with atopy still remains controversial 
(Mancuso et al., 2004; Wong et al., 2007). Further than allergic inflammation as a possible 
pathway to asthma mediated by leptin, this hormone seems to also have some up-regulatory 
effect on the sympathetic nervous system, although it does not seem to be important in 
regulating airway smooth muscle tone (Nair et al., 2008), a fact which might be in 
connection to the non-consistent findings related to the association between obesity and 
BHR. However, its is interesting that leptin and leptin receptor are significantly reduced in 
bronchial epithelial cells in patients with mild asthma which is uncontrolled and in severe 
treated asthmatics as compared to mild asthmatics under good control, and healthy 
controls. Additionally, leptin and leptin receptor expression correlated inversely with the 
thickness of the basement membrane, which is a salient feature of lung remodeling (Bruno 
et al., 2009). 
2.4.1.2 Adiponectin 
Adiponectin has an anti-inflammatory role, and decreases with increasing obesity. Contrary 
to this apparent anti-inflammatory role favoured by obesity, adiponectin is increased in 
other chronic inflammatory conditions such as rheumatoid arthritis, systemic lupus 
erythematosus or inflammatory bowel disease. Moreover, elevated levels of adiponectin in 
cord blood have been associated with an increased risk of asthma in children born from 
atopic mothers (Rothenbacher et al., 2007). More importantly, adiponectin decreases during 
puberty only in boys, and remains unchanged in girls (Andersen et al., 2007), a situation that 
would make gender a modifying factor in the association between obesity and asthma 
during puberty. Adiponectin and all its currently known receptors are expressed in multiple 
cell types in the lung (Hug et al., 2004; Miller et al., 2009; Takemura et al., 2007) which makes 
it a suitable candidate for an additional link between obesity and asthma. In ovoalbumin 
sensitized mice, administration of exogenous adiponectin protects against cell infiltration 
and cytokine levels. Serum adiponectin reduces allergic airway inflammation and BHR in 
mice (Shore et al., 2006). On the other hand and also in mice, adiponectin inhibits the 
proliferation of vessels associated to smooth muscles although it does not affect muscle itself  
(Medoff et al., 2009). These findings suggest that adiponectin is involved in allergic 
inflammation and pulmonary vascular remodeling in a mouse model of chronic asthma. 
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The number of studies in humans is scarce and the study by Rothenbacher et al. 
(Rothenbacher et al., 2007) seems to be contradictory to the animal model. Among children 
with a maternal history of atopy, lower level of adiponectin was associated to lower 
incidence of asthma or obstructive bronchitis during the first two years of life. Conversely, 
higher levels of cord serum adiponectin were associated to higher incidence of those 
respiratory conditions. Among those children without a maternal history of atopy, there was 
no association of the adipokine and the incidence of asthma or obstructive bronchitis. Other 
epidemiological studies in humans have rendered inconclusive results. In two cross-
sectional studies with a relatively low number of school children, serum adiponectin was 
not associated to an ever diagnosis of asthma (Nagel et al., 2009) or to current asthma 
confirmed by metacholine challenge test (Kim et al., 2008). In two very large epidemiological 
studies in adults, although a clear association between higher BMI and asthma was found in 
both of them, adiponectin was only inversely associated with current asthma in 
premenopausal women in one. In a more recent study, 368 adolescent asthmatics were 
followed for one year: adiponectin was inversely associated to asthma symptoms and 
exacerbations and positively to FEV1/FVC but only in male subjects (Kattan et al., 2010). 
FeNO was not associated to serum adiponectin. Conversely, a study in adults did find that 
adiponectin was associated to lower values of FeNO in men but not in women. No further 
association of the adipokine and different asthma markers was found in any gender. 
(Sutherland et al., 2009). 
2.4.1.3 Resistin 
Resistin is also known as adipocyte-secreted factor or “found in inflammatory zone 3” 
(FIZZ3). It has recently been discovered and has been proposed as a link between obesity 
and diabetes. In contrast to mice, resistin is expressed in human adipocytes in low amounts; 
in fact it is in bone marrow where this adipokine is most expressed in humans (Filkova et 
al., 2009). Resistin has recently been shown to initiate a pro-inflammmatory state “in vitro” 
and “in vivo”. Pro-inflammatory mediators such as TNF-┙, IL-1┚ or IL-6 can strongly 
increase the expression of resistin in peripheral mononuclear cells. As stated above, resistin 
is minimally expressed in human adipose tissue, but adipocytes may be targets for it. 
Nagaev et al. have demonstrated that resistin, similarly to its action on peripheral blood 
mononuclear cells, can induce adipocytes to express IL-6 and TNF-┙ (Nagaev et al., 2006). 
Resistin has been shown to be increased in the murine models of genetic as well as in diet-
induced obesity. This has also been shown in humans. In an asthma cohort study on adult 
asthma, levels of resistin were higher in asthmatic patients as compared to controls, and 
resistin levels increased with increased severity of the disease (Larochelle et al., 2007). 
Conversely, atopic asthmatic children have lower resistin levels as compared to the non-
atopic asthma and control groups (Kim et al., 2008). However, in a recent study (Arshi et al., 
2010) in children of a similar age to those in the previous study (11 years) resistin levels 
were not different between a group of atopic asthmatics and a control group. In fact, its 
levels in the former study were about double than in the latter both in the control and in the 
atopic asthmatic groups. More recently, a study has shown that in a group of non-obese 
corticosteroid naïve adult female recently diagnosed asthmatics resistin predicted 
favourable anti-inflammatory effects of inhaled corticosteroids as assessed by levels of 
eosinophil cationic protein, eosinophil protein X and myeloperoxidase. Furthermore, an “in 
vitro” assay found that fluticasone significantly reduced resistin-induced IL-6 and TNF-┙ 
production in cultured monocytes/macrophages (Leivo-Korpela et al., 2011). 
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2.4.1.4 Adipsin 
This adipokine is the rate-limiting enzyme in the alternate pathway of complement 
activation and is primarily expressed by adipocytes and monocytes/macrophages in 
humans. Adipsin has however been barely studied in asthma or allergic diseases. In a group 
of non-obese corticosteroid naïve adult female recently diagnosed asthmatics and with a 
positive bronchodilator tests, levels of adipsin were similar to the control group (Leivo-
Korpela et al., 2011); however this adipokine has been reported to be significantly increased 
in individuals with seasonal allergic rhinitis, but only in males. Sublingual immunotherapy 
did not seem to affect adipsin levels (Ciprandi et al., 2009). Information regarding whether 
adipsin might have a role in asthma (if any) is still very scarce and we will have to wait until 
new studies publish their results. 
2.4.1.5 Visfatin 
Visfatin is identical to pre-B cell colony enhancing factor, a cytokine which is increased in 
the bronchoalveolar lavage fluid in animal models of acute lung injury and in neutrophils of 
septic patients. Exercise training with weight loss induced a significant reduction of plasma 
visfatin in non-diabetic women (Choi et al., 2007). Although this protein represents an 
additional link between obesity and inflammation, its role in asthma (if any) is still to be 
elucidated. 
2.4.2 Immunologic properties of adipose tissue 
The view of adipose tissue as a sole storage system has radically changed in the last decade. 
Further than being able to synthesize adipokines, adipocytes share some similarities with 
macrophages. In fact, preadipocytes can differentiate into macrophages, but the two cell types 
are distinct. On the other hand, about 10% of cells in the adipose tissue are macrophages. The 
number of macrophages in the adipose tissue is directly related to adiposity and to the size of 
adipocytes both in humans and in mice (Curat et al., 2004). Apart from secreting adipokines, 
adipocytes also secrete chemokines and cytokines, such as TNF-┙, IL-6, Il-10, IL-1┚ and other 
factors such as monocyte chemoattractant protein-1 (MCP-1). It is thought that those mediators 
are secreted by the adipocyte itself since when adipose tissue is increased there is an up-
regulation of genes related to inflammation. Indeed macrophages of the adipose tissue are an 
additional source of inflammatory mediators. 
- TNF-┙ is the most important of cytokines produced by adipose tissue. It increases 
formation of Th2 cytokines such as IL-4 and Il-5, IL-6 and Il-1┚ by the bronchial 
epithelial cells. On the other hand, TNF-┙ increases the expression of leptin and 
adiponectin in cultured adipocytes (Kirchgessner et al., 1997). TNF-┙ is an important 
cytokine in the innate immune response and has been involved in the pathophysiology 
of several chronic inflammation diseases, including asthma (Thomas et al., 1995; 
Thomas & Heywood, 2002). This cytokine has an array of effects on the immunological 
system which have direct implications for the asthmatic response, such as recruitment 
of neutrophils, macrophages and mast cells; recruitment and activation of eosinophils; 
up-regulation of adhesion molecules both in the respiratory epithelium and on the 
vascular endothelium, which in turn can further increase inflammatory cell recruitment; 
proliferation and differentiation of fibroblasts (related to asthma remodeling and 
potentially to a more severe type of asthma); activation and increased release of 
cytokines by T cells of the Th2 arm; and induction of corticoisteroid resistance 
(Brightling et al., 2008). 
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- IL-6 is a proinflammatory cytokine which has a central role in host defence against 
infection and tissue injury. This interleukin derived from antigen presenting cells can 
induce production of IL-4 in naïve CD4+ cells, thus polarizing them into Th2 cells; i.e. to 
the allergic type of inflammation. This interleukin also modulates the intensity of the 
immune response by inhibiting Treg cell development. Additionally IL-6 promotes 
generation of Th17 cells (cells involved in autoimmune diseases) in mice, though its 
ability to do so in humans is subject to debate (Wilson et al., 2007). It has been recently 
shown that IL-6 levels are elevated in sputum of asthmatic patients as compared to 
healthy volunteers (Neveu et al., 2010). 
- IL-10 is a cytokine with important regulatory function, having multiple biological 
effects in different cell-types. IL-10 modulates allergic disease in humans: the expression 
of IL-10 by antigen presenting cells in the airway of healthy subjects is important for 
inducing and maintaining tolerance to allergens (Commins et al., 2008). 
- IL-1┚ is a potent mediator in response to infection and injury, and is increased in 
asthmatic airways as it is in other chronic inflammatory diseases. Apart from its pro-
inflammatory effects, IL-1┚ has been shown to induce migration of vascular smooth 
muscle cells in culture and to provoke migration of endothelial cells. Its potential effects 
on the airway epithelial cell have been recently shown in cell cultures (White et al., 
2008). 
It should not be forgotten that apart from adipocytes, adipose tissue contains a considerable 
number of macrophages. Those cells are located in the white adipose tissue, which –as 
compared to brown adipose tissue which has as main role non-shivering thermogenesis- is 
the majority of adipose tissue and serves as energy storage. The number of macrophages in 
this tissue is proportional to adiposity and adipocyte size, both in mice and humans, and no 
difference exists between visceral and subcutaneous white fat (Weisberg et al., 2003). 
2.4.3 Other endogenous molecules relating obesity with asthma 
There are other hormones which may be related to obesity and asthma since they can be 
associated with processes related to food intake/body weight and inflammation. 
2.4.3.1 Alpha-melanocyte stimulating hormone 
Alpha-melanocyte stimulating hormone (┙-MSH) belongs to a group of hormones called 
melanocortins, which include ACTH among others, with a common precursor 
(proopiomelanocortin). This hormone produces a significant down-regulation of pro-
inflammatory cytokines such as IL-1┚, IL-6 and TNF-┙, as well as chemokines such as IL-8 
and interferon gamma (IFN-┛). Furthermore, chemotaxis induced by IL-8 in human 
neutrophils and monocytes is blunted by ┙-MSH. Additionally, this hormone has been 
shown to induce IL-10 production (Brzoska et al., 2010). In a murine model, ┙-MSH was able 
to inhibit airway inflammation induced by aerosol sensitization and subsequent challenges 
with OVA. Additionally, the levels of two important interleukins related to the allergic 
response, IL-4 and IL-13, were highly decreased in the broncho-alveolar lavage fluid of mice 
treated with ┙-MSH. In agreement with the important role of IL-10 as an anti-inflammatory 
mediator, the action of ┙-MSH was dependent on the presence of IL-10, as IL-10 knock-out 
mice were resistant to treatment with ┙-MSH (Raap et al., 2003). In the context of an 
association between asthma and obesity, what is on interest of ┙-MSH is the fact that the 
hormone is included in one of the main mechanisms of energy balance. There are 
melanocortin receptors in the CNS and effects on food intake and on energy expenditure 
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have been observed with treatments containing ligands of those receptors (Williams et al., 
2000). Those receptors are hypothesized to be downstream mediators of the effects of leptin 
signaling: leptin increases the expression of the proopiomelanocortin gene in neurons of the 
nucleus tractus solitarius  (Schwartz et al., 1997). Thus, ┙-MSH may play a role both in 
allergic inflammation and in food-intake control. In fact, the melanocortin system appears to 
be a common pathway for mediation of both leptin and ghrelin (Lebrethon et al., 2007). 
2.4.3.2 Ghrelin 
Ghrelin is not only a mere growth-hormone releasing factor but also an important appetite 
regulator, energy conservator and suppressor of the sympathetic nervous system. Ghrelin, 
secreted from the peripheral organ, has its regulatory region in the hypothalamic arcuate 
nucleus, where the regulatory region of appetite is located. Circulating ghrelin excites this 
region and stimulates food intake after passing through the blood-brain barrier. Additionally, 
this hormone can exert its action through receptors in the vagus nerve  (Kojima & Kangawa, 
2010). Apart from being an orexigenic hormone, ghrelin has an interesting association with IgE 
in humans. In a case-control study of obese school children, Matsuda et al. (Matsuda et al., 
2006) found that ghrelin was inversely and significantly correlated with BMI but also with IgE 
both in allergic and non-allergic subjects as defined from a combination of asthma and skin 
symptoms. This correlation with IgE is higher among overweight patients as compared to 
normal weight ones, in which the correlation is still significant (Okamatsu et al., 2009). The 
strong inverse correlation between plasma ghrelin and serum IgE levels suggests that ghrelin 
may inhibit IgE production in some manner. In this context, it is of interest that in splenic 
murine T lymphocytes, mRNA levels of IL-4 and IL-10, which both increase IgE synthesis, are 
suppressed by ghrelin (Xia et al., 2004). 
2.4.3.3 Eotaxin 
Eotaxin is a key chemotactic agent responsible for the eosinophil-mediated bronchial 
inflammation. In their pivotal study, Vasudevan et al. (Vasudevan et al., 2006) showed that 
eotaxin circulating levels are increased in diet-induced obese mice. They also showed that 
after weight loss in humans eotaxin was significantly reduced. In a group of obese and non-
obese Korean women it was shown that circulating eotaxin was similar in both groups, 
although women with central obesity had significantly higher levels of eotaxin than those 
without it. This study also showed that weight reduction after following an exercise 
program for 12 weeks was associated to a significant decrease in circulating eotaxin levels in 
the whole group (Choi et al., 2007). 
Not only has eotaxin been studied in relation to obesity but also as to how this chemokine 
interacts with allergy inflammation in the context of obesity. In a murine allergy model  
(Calixto et al., 2010), diet-induced obesity enhanced eosinophil trafficking from bone 
marrow to lung tissues, and delayed their transit through the airway epithelium into the 
airway lumen. Consequently, eosinophils remain longer in lung peribronchiolar segments. 
Furthermore, Kim et al.  (Kim et al., 2011) cultivated and differentiated pre-adypocites and 
investigated eotaxin expression during differentiation and found that levels of this 
chemokine increased as adipocytes differentiated. Eotaxin was further expressed when 
cultured cells were challenged with TNF-┙ and IL-4.  
2.4.3.4 Plasminogen activator inhibitor 1 
Remodeling of the airway is a key feature of asthma and is associated to a more severe type 
of disease. Plasminogen activator inhibitor 1 (PAI-1) is a potent inhibitor of both tissue-type 
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plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA). Both t-PA 
and u-PA are involved in the dissolution of fibrin and in the degradation of the extracellular 
matrix. Activated mast cells are a major source of PAI-1, and mast cell-derived PAI-1 is 
highly expressed in patients with fatal asthma (Cho et al., 2000). Furthermore, a gene 
polymorphism associated with PAI-1 levels is preferably transmitted to asthmatic patients; 
and deletion of PAI-1 prevents extracellular matrix deposition in a murine model of asthma 
(Cho et al., 2001); (Oh et al., 2002). In a very recent study (Cho et al., 2011), it was found that 
plasma levels of PAI-1 were significantly higher in obese subjects as compared to controls 
after adjusting for race and smoking status; furthermore, PAI-1 plasma levels were 
significantly and inversely correlated to forced vital capacity. Thus, it could be hypothesized 
that the reduction of FVC in obese patients may be in part mediated by PAI-1. Although 
research on the association of PAI-1 as a link between obesity and asthma is still very scarce, 
this is a field which warrants further investigation.  
2.5 The mechanical link 
The mechanical load of obesity might affect lung growth, leading to reduced pulmonary 
function. For instance, leptin-deficient mice which are obese very early in their development 
have substantially smaller lungs than normal ones (Shore et al., 2003). Maternal obesity in 
pregnancy increases the risk of pregnancy complications, caesarean sections and adverse 
birth outcomes, which have in turn been associated with respiratory illness in children. 
However, little is known of the effect of obesity in the mother during pregnancy with regard 
to respiratory diseases in the offspring. A recent Norwegian study (Haberg et al., 2009) 
(Norwegian and Child Study) which includes 100,000 pregnant mothers was able to analyse 
data from more than 33,000 mother-children pairs up to the age of 18 months of the infants 
and demonstrated that after adjustment for many factors including birth weight, preterm 
birth and pregnancy complications, infants born from obese mothers had a modest but 
significant increased risk (3.3%) of suffering from at least one episode of wheezing during 
the follow-up period. To what extent this finding is related to the low-grade inflammation 
status of mothers during pregnancy or to mechanical factors “in utero” and how they might 
affect lung development in the foetus is still to be determined. Furthermore, it is not known 
if this effect is maintained in later years. 
Independently of its effects on lung development either in the fetal period or later on, obese 
subjects have a low functional residual capacity due to changes in the elastic properties of 
the chest wall (Shore & Johnston, 2006). At low volumes, the retractile forces of the lung 
parenchyma are reduced, thus airway smooth muscle has a lower load when functional 
residual capacity is reduced. Consequently it might shorten still further when activated 
(either by parasympathetic tone or broncho-constricting agents such as metacholine) 
(Naimark & Cherniack, 1960). However, some studies have noted that there is bronchial 
constriction in obese subjects after correcting for lung volume, which suggests that other 
mechanisms are involved. Apparently low tidal volume (which is common in obese 
individuals) may be one such mechanism: stretching of the airways smooth muscles causes 
cross-bridging of actin-myosin to detach, and the bigger the tidal volume (stretch) the easier 
it is for bronchodilation to occur. Low tidal volume facilitates more cross-bridging between 
actin and myosin, thus making airway smooth muscle stiffer and harder to stretch. Hence 
reduction of tidal volume in obese subjects could lead to a vicious circle in which small 
airway muscle strain leads to greater stiffness, and this leads to even less muscle strain in 
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every breath (Shore, 2008). This paradigm is supported by the fact that both obese and 
asthmatic subjects have lower bronchodilation after deep breaths (Hakala et al., 1995; Skloot 
& Togias, 2003). 
There could be additional mechanical explanations as to the reasons why airways in obese 
subjects are more easily constricted than in normal ones. Closure of small peripheral 
airways is common in obese individuals, especially in the supine posture (Hakala et al., 
1995). Some authors have postulated that the frequent opening and closure of those airways 
may lead to the rupture of alveolar attachment to bronchioles, thus disconnecting airways 
from the attached parenchyma and exacerbating constriction (Milic-Emili et al., 2007). To 
what extent those less oxygenated areas could lead to higher artery pressures and 
pulmonary edema, further complicating the situation, is still very speculative although there 
is some evidence of edema in obese subjects and pulmonary hypertension in obese women  
(Bergeron et al., 2005); (Taraseviciute & Voelkel, 2006). Hypoxemia might exacerbate local 
hypoxia occurring in obese adipose tissue, a situation which contributes to the general 
inflammation of obesity (Hosogai et al., 2007; Ye et al., 2007). Situations related to obesity 
such as obesity hypoventilation syndrome or sleep disordered breathing could further 
aggravate this situation and although extreme and far from asthma, could add some clues to 
the mechanical associations between asthma and obesity. 
2.6 The experimental link (animal models) 
Three are several models in which the lung features of obese mice have been characterized. 
According to Shore (Shore, 2007), those are: 
- ob/ob Mice: This is a type of mice which is not capable of synthesizing leptin, which is a 
satiety hormone formed in the adipose tissue. These mice eat in excess and are already 
obese at four weeks of age. These mice have smaller lungs than the wild type. 
- db/db Mice: In this type of mice there is an altered leptin receptor in the hypothalamus 
(Ob-Rb) so the effect of leptin on satiety is lost. Thus, db/db mice are similar to ob/ob 
mice. As in the case of ob/ob mice, db/db mice have smaller lungs than the wild type. 
- Cpefat Mice: These mice have a missense mutation of the enzyme carboxipeptidase E 
(Cpe) which makes it inactive. Cpe cleaves neuropeptides such as corticotrophin-
releasing factor and neuropeptide Y which control eating behaviours and energy 
consumption. In the absence of Cpe mice become obese but not as fast as ob/ob or db/db 
mice. These mice have lung size comparable to that of the wild type. 
- Diet-induced obese mice: feeding recently weaned mice with a diet in which 45-60% of 
calories are derived from fat produces obesity. Obesity is milder than in the three prior 
models and lung size is again similar to that of the wild type. 
Taken together, the results from the studies from animal models in obese mice suggest that 
obesity might be related to asthma in several ways. In the first place very early obese mice 
have smaller lungs and this might have implications both at the mechanical and at the ultra-
structural level, in particular in the way lungs are alveolarized. Secondly, obesity either 
acquired very early or later on in the mice’s lives increases BHR and this neither seems to be 
directly mediated by leptin nor is secondary to a prior inflammation. Lastly, obesity might 
have some effect on asthma through allergic sensitization as that hormone seems to increase 
sensitization, and thus BHR to allergen challenge (Shore et al., 2005), this being dependent 
on when obesity and sensitization develop. 
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2.7 A distinct asthma phenotype in the obese? 
There seems to be enough epidemiological, clinical and mechanistic evidence that obesity 
and asthma “live” together in some individuals. Whether this comorbidity is a distinct 
phenotype as suggested by some authors; or obesity is a risk factor for asthma incidence and 
worse control, is difficult to say (Castro-Rodriguez & Garcia-Marcos, 2008; Lessard et al., 
2008; Lugogo et al., 2010). However, both the mechanical, hormonal and immunological 
links between the two conditions suggest that obesity probably leads to asthma in many 
cases and could be in part responsible for the “asthma epidemic”. Moreover, there are two 
other important factors –diet and exercise- which can favour both asthma and obesity in 
parallel. An official American Thoracic Society workshop report recently published 
concludes that obesity is a risk factor for asthma in all age groups and that asthma in the 
obese might represent a distinct phenotype with a more severe disease with a worse 
response to treatment (Dixon et al., 2010). The report states the urgent need to further 
investigate the mechanisms of asthma in this risk group and to develop new therapies 
directed to this specific population. 
3. Diet as an independent factor in the development of asthma and obesity 
Diet and exercise are probable common pathways for asthma and obesity irrespective of 
which of the two conditions starts first. This is quite well documented during the first 
months after birth. Infants who are breastfed have a different bacterial colonization of their 
intestine than those who are fed with artificial formulas (Harmsen et al., 2000). Similarly, 
children fed with the latter formulas gain weight more rapidly, although this does not seem 
to be translated into later obesity (Burdette et al., 2006). Although the information is still 
sparse, it is quite probable that the so-called microflora fingerprinting –which remains very 
stable throughout the years- is related to diet. Either by this mechanism which might be 
included into de hygiene hypothesis or by others, such as the antioxidant or pro-oxidant 
properties of some foods (Roberts et al., 2006), or the modulating  properties of prebiotics -
like fibers- to adjust intestinal microflora (Schley & Field, 2002), may have an effect on 
asthma and obesity. 
There are currently enough studies to conclude that there is an association between 
consumption of some types of nutrients or foods and asthma. An ecological analysis of the 
European Community Respiratory Health Survey (ECRHS) showed a trend towards 
decreasing sensitization (specific IgE) prevalence with higher intakes of fruit and vitamins A 
and C (Farchi et al., 2003). Furthermore, other studies have found an association between 
consuming citrus/kiwi fruit and a lower last year prevalence of several asthma symptoms 
(Forastiere et al., 2000; Wickens et al., 2005); and also of rhinitis. The frequent intake of 
vegetables showed an inverse relationship with prevalence rates of asthma, allergic 
rhinoconjunctivitis and atopic eczema (Weiland et al., 1999). The intake of cereals has also 
been shown to be associated to a lower prevalence of asthma (Garcia-Marcos et al., 2007; To 
et al., 2004). A recent meta-analysis on food intake and asthma arrived at interesting 
conclusions (Nurmatov et al., 2011) in spite of the limitations of applying the meta-analysis 
technique to epidemiological studies which cannot be –by definition- perfectly controlled. 
With respect to individual nutrients, vitamins A, D, E and zinc seem to be protective, while 
vitamin C and selenium do seem to be neither a protective nor a risk factor. Higher 
consumption of fruit and vegetables are associated to a lower prevalence of asthma, with 
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fruit having a higher impact. However the associations were not adjusted for obesity or 
exercise. 
Two different groups, including ours, have very recently associated Mediterranean diet to a 
lower prevalence of asthma at different ages (Castro-Rodriguez et al., 2008; Chatzi et al., 
2007; Garcia-Marcos et al., 2007) independently of exercise. Furthermore, Mediterranean diet 
also showed this protective effect in the offspring when the mother consumed it during 
pregnancy (Chatzi et al., 2008), although the effect might be restricted just to olive oil intake 
(Castro-Rodriguez et al., 2010). The reasons why this type of diet is associated with a lower 
prevalence of asthma could be explained in several ways. Considering that Mediterranean 
diet is rich in both antioxidants and cis monounsaturated fatty acids this is not an 
unexpected finding. Individually, a more frequent intake of seafood and also of cereals is 
associated with a lower prevalence of significant asthma. At 8-10 years of age atopy is a risk 
factor for a more severe asthma (Ponsonby et al., 2002), so it could be speculated that at least 
in part the protection offered by this diet is mediated through allergy modulation. The 
protection from asthma that Mediterranean diet seems to offer is probably due to a mixed 
effect of taking “protective” foods and avoiding “risky” foods. Protective foods may be 
those with antioxidant properties and rich in prebiotics, such as fibers (as in the 
Mediterranean diet); and risky foods may be those rich in trans fatty acids and unsaturated 
fat (as in fast foods)  (Garcia-Marcos et al., 2007; Innis & King, 1999; von Kries et al., 2001). In 
fact, Mediterranean diet has been shown to increase the total antioxidant capacity in healthy 
adults (Pitsavos et al., 2005). Mediterranean diet has additionally been associated to a 
reduced prevalence of obesity. Due to its content in fibre and unsaturated fat (olive oil, fish) 
this diet is associated to better weight control (Schroder, 2007). On the contrary, fast food is 
related to an increase of calorie intake (Schmidt et al., 2005) and is greatly related to the 
school and family environment, especially during the transition to adulthood (Nelson et al., 
2006)  
3.1 Oxidant-antioxidant imbalance in asthma 
Reactive oxygen species (ROS), formed in every cell during metabolic processes, are 
increased in asthma and can mediate pathophysiologic changes which are characteristic of 
this condition, such as initiating lipid peroxidation and favouring the release of arachidonic 
acid from cell membranes; contracting smooth muscle; increasing airway reactivity and 
vascular permeability; augmenting the synthesis and release of cytokines and chemokines; 
impairing the response to ┚2 adrenergic drugs; and decreasing cholinesterase and neutral 
endopeptidase activities (Nadeem et al., 2008). Lungs have several antioxidant mechanisms 
including enzymatic (catalase, glutathione peroxidase ans superoxide dismutase) and non-
enzymatic ones (vitamin C, E, albumin, uric acid, cerulopasmin and glutathione). Increased 
ROS generation is found when the activity of neutrophils, eosinophils, monocytes and 
macrophages is increased, as occurs in asthma (Kelly et al., 1988). Oxidative stress (a 
situation of imbalance between the production of ROS and the ability to detoxify the 
reactive intermediates or to repair the resulting damage) is an important consequence of 
asthma inflammation; is associated with an altered activity in anti-oxidation in lungs and 
blood; and also with airway reactivity (Katsumata et al., 1990; Nadeem et al., 2005; Sackesen 
et al., 2008). 
There are numerous reports showing deficiencies of antioxidants in asthma: low levels of 
vitamin C in airway lining fluid, serum, plasma, whole blood and brochoalveolar lavage 
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fluid; vitamin E in brochio-alveolar lavage fluid, red cells and plasma; or beta-carotene in 
serum (Kalayci et al., 2000; Kelly et al., 1999; Sackesen et al., 2008; Shanmugasundaram et al., 
2001; Vural & Uzun, 2000; Wood et al., 2008). The cooperation of several antioxidants 
provides a better defense against ROS, so the total antioxidant capacity of serum is probably 
a better index than the measurement of a specific antioxidant. Again, antioxidant capacity in 
serum is reduced in asthmatics during exacerbations as compared with healthy individuals 
and is less reduced in subjects with stable asthma (Katsoulis et al., 2003). Very recently, 
oxidative stress has been shown to be increased in children with previous bronchilitis 
obliterans (Mallol et al., 2011) and although in this study the authors did not find correlation 
with lung function tests, several studies have indeed shown an inverse relationship between 
oxidative stress and lung function in asthmatics (Nadeem et al., 2005; Ochs-Balcom et al., 
2006; Picado et al., 2001; Wood et al., 2000). 
Taken together these results indicate that an oxidant-antioxidant imbalance could play a 
crucial role in the development of asthma symptoms and in the severity of the disease. 
Accordingly, certain diets may favor or protect from asthma depending upon their ability to 
maintain a better oxidant-antioxidant balance. 
4. Exercise is an independent protective factor for asthma and obesity 
Although it would be expected that asthmatics perform less exercise and severe asthmatic 
perform even less, it is not so straightforward that the lack of exercise favours obesity, which 
in turn favours asthma. Although this causal pathway may be present in some asthmatics, 
more exercise –independently of BMI- has been associated to a lower prevalence of mild 
asthma, although it does not influence severe asthma. If the association of asthma with 
exercise was a reverse causation effect it should be expected that at least in severe 
asthmatics, there was an inverse association, which does not seem the case when diet and 
BMI are controlled: in their study Garcia-Marcos et al. showed that after adjusting for BMI 
and Mediterranean diet exercise was not associated with severe asthma; and mild asthma 
was less prevalent among children who exercise more (Garcia-Marcos et al., 2007). 
Therefore, it might be hypothesized that at least in mild cases, the lack of exercise is 
associated to asthma. In this context, a very interesting and challenging hypothesis was 
proposed by Alexander in 2005 who maintains that the increase of asthma prevalence might 
be due in part to a “disuse contracture” which reminds of the mechanical link between 
obesity and asthma (Alexander, 2005). The following paragraphs are a brief explanation of 
that hypothesis. 
Bronchial constriction and BHR are crucial features of asthma and are both driven by 
bronchial smooth muscle. When lumen is narrower than normal in a permanent way, there 
is also a reduction in the length of the annular components of the bronchii, namely smooth 
muscle fibres and collagen. Under-extension causes contracture:  elastic components 
(smooth muscle and collagen) need a certain tension to operate correctly and when this is 
not provided by intermittent stretching they either fail to extend during growth (infants and 
schoolchildren) or reduce in length (adults) to a point in which habitual usage is enough to 
provoke a peak tension needed for effective functioning. This situation maybe reversible in 
its first stages but becomes permanent with time due to fixed cross-linking (Akeson et al., 
1977). While this is typical of the joint tissues, it is most probably applicable to muscles and 
elastic tissues of the airways, which in continued growing (as in infancy and childhood) 
without stretching to their potential length the result would result in an increased thickness 
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of the wall and narrowing of the lumen, which, in turn, will start a vicious cycle: thicker 
wall, less ability to stretch and more difficult distension to inspiration, less distension, less 
lumen and thicker wall again. If lumen is reduced to a critical point and according to 
Laplace’s law, the product of atmospheric pressure times radius will not be able to 
counteract wall tension and bronchii would collapse. In this situation a very small increase 
of muscle tone will be enough to cause bronchial closure. Moreover, exercise increases 
respiratory rate and speed of airflow, thus reducing transmural pressure and further 
favouring collapse. 
In summary, this hypothesis contemplates asthma as a lack of lung expansion by exercise 
during growth. While just a hypothesis, the idea of a lack of “sufficient” inspiration has been 
contemplated as a feasible explanation for the influence in asthma prevalence of TV 
watching. The ALSPAC study, after following a large sample of more than 5,000 children, 
found that new asthma cases, as diagnosed by a doctor, between the ages of 3.5 and 11.5 
years were associated to the number of hours of TV watching after controlling for other risk 
factors including BMI: those watching more than 2h/day had double odds of having new 
onset asthma a compared to those watching 1-2h/day, while those watching less than 
1h/day had just half the odds (Sherriff et al., 2009). While previous studies showed that new 
cases of asthma during adolescence are associated to lower fitness (Rasmussen et al., 2000; 
Vogelberg et al., 2007), sometimes confused by smoking, children in the ALSPAC study 
were too young to consider smoking-related TV watching as a plausible explanation. 
Sedentary lifestyle (“disuse contracture”) is a more plausible explanation. Additionally, the 
ALSPAC group suggested as an additional explanation of their results that respiratory 
patterns associated to TV watching may also play a role: prolonged periods of watching a 
videotape are associated with lower sigh rates than while reading (Hark et al., 2005). Thus, 
“modern” as opposed to “classical” sedentary lifestyle maybe and additional factor 
favouring the “disuse contracture”. 
5. Conclusion 
Obesity and asthma are linked together, a link which has been shown at different levels and 
has plausible pathways. However, it is still to be established if obesity causes asthma (or a 
specific asthma phenotype) or if the two conditions are part of a parallel development in the 
context of the western lifestyle in which sedentary habits and unhealthy diets (together with 
lower contact with germs and/or with “non-traditional” germs) may interact to favour an 
internal environment in which not only obesity and asthma, but other diseases such as type 
II diabetes or rheumatoid arthritis develop more easily. 
The epidemiological and animal studies carried out to date have probably rendered all 
possible information and it is the time of more controlled trials. New pregnancy/birth 
cohort studies specifically designed to disentangle the interrelationship between asthma, 
obesity, exercise and diet are needed. Creative clinical trials will also have an important role 
here, although designing and performing them is a great challenge. The implications of the 
results of such studies on public health policies are crucial. 
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